【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the World Market for Antithrombotic Drugs
1.2 Why Should You Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
1.10 Glossary of Abbreviations
2. Blood Clotting: Mechanisms, Disorders and Current Treatments
2.1 Understanding Haemostasis and Coagulation
2.2 What is Thrombosis
2.3 Complications of Thrombosis
2.3.1 Pulmonary Embolism: A Thrombus Blocking Blood Supply to the Lungs
2.3.2 Stroke Results From Blockage of Blood Flow to the Brain
2.3.3 Acute Coronary Syndrome (ACS): Blockage of Blood Supply to the Heart
2.4 Antithrombotic Drug Treatment
3. Antithrombotic Drugs: World Market 2015-2025
3.1 The World Antithrombotic Drug Market in 2013 and 2014
3.2 The World Antithrombotic Drug Market: Overarching Revenue Forecast 2014-2025
3.3 Driving and Restraining Forces Affecting the Antithrombotic Drugs Market
3.3.1 An Increasing Patient Population Drives Market Growth
3.3.2 Intense Competition from Generics Threatens to Restrain the Market
3.4 The Antithrombotic Drug Market by Therapeutic Class: Revenue and Market Share Predictions, 2019 and 2025
3.5 The Future of the World Market for Antithrombotic Drugs by Therapeutic Class: Grouped Revenue Forecasts, 2014-2025
3.6 Anticoagulant Drugs: Leading the Market from 2014 Onwards
3.6.1 Direct Factor Xa Inhibitors: A Novel Therapeutic Class With Great Potential
3.6.2 Heparins: Second-Leading Anticoagulant Class in 2013
3.6.3 Direct Thrombin Inhibitors Achieved High Growth in 2013 and 2014
3.6.4 Vitamin K Antagonists Have Led the Anticoagulant Drug Market for 60 Years
3.7 Antiplatelet Drugs Were the Second-Leading Therapeutic Class in 2014
3.8 Fibrinolytics Will Continue to be a Staple of the Antithrombotic Drug Market
4. Leading Products in the Market: Prospects, 2015-2025
4.1 Plavix and Lovenox Remain the Market Leaders in 2012 and 2013, Despite Generic Competition
4.2 The Leading Antithrombotic Drugs: Comparison of Revenue and Market Share, 2019 and 2025
4.3 Which Medicines Will Achieve the Highest Rate of Growth to 2025?
4.4 Plavix Faces Competition from Generics, So What Does the Future Hold?
4.4.1 Branded Competition for Plavix?
4.5 Lovenox: Biosimilar Competition in the EU is Expected
4.6 Xarelto: Leading Antithrombotic of 2014
4.7 Pradaxa’s Continued Growth in 2014
4.8 Activase Leads the Fibrinolytics Market, With Little Competition
4.9 Effient Competes with Brilinta/Brilique as well as Generic Competition for Plavix
4.10 Aspirin Cardio: The Most Lucrative Version of Acetylsalicylic Acid
4.11 Angiomax/Angiox is Losing Share of the Direct Thrombin Inhibitors Market to Pradaxa
4.12 Pletal Faces Generic Competition and Restrictions on Use in Europe
4.13 Aggrenox/Asasantin to Face Generic Competition Earlier Than Expected in the US
4.14 Sandoz’s Enoxaparin Sodium: Revenue Forecast 2014-2025
4.15 Fragmin Faces Rivalry from Generic Competition to Lovenox
4.16 Brilinta/Brilique: Investigation Closed in 2014
4.17 Eliquis: Will Late Entry to the Market Affect Uptake?
4.18 Arixtra: Aspen Pharmacare Has Acquired Worldwide Rights from GSK
4.19 New Approvals in the Antithrombotic Drugs Market, 2014
4.19.1 Zontivity: The Newest Approval in Antithrombotics
4.19.2 Lixiana/Savaysa: Expansion into Other Regional Markets
5. Leading National Markets, 2014-2025
5.1 Which Were the Leading National Markets for Sales of Antithrombotic Drugs in 2013 and 2014?
5.2 The Leading National Markets for Antithrombotic Drugs: Comparison of Revenues and Market Shares, 2019 and 2025
5.3 Which National Markets Will Grow Fastest to 2025?
5.4 The US: Dominating the Antithrombotic Drug Market Through 2014-2025
5.5 The EU5: Are the Guidelines for Approval of Biosimilar LMWHs Set to Change?
5.5.1 Germany Leads the EU5
5.5.2 France: Healthcare System Reform Will Inhibit Sales Growth?
5.5.3 UK: Pharmaceutical Price Regulation Scheme
5.5.4 Italy’s Healthcare System – Advantages Conducive to Business
5.5.5 Spain: Reductions in Governmental Healthcare Spending Will Restrict Growth
5.6 Japan: The Aging Population Will Stimulate Demand for Antithrombotic Drugs from 2015-2025
5.7 Chinese Antithrombotic Drug Market Will Capture Market Share
5.8 Brazilian Antithrombotic Drug Market 2015-2025: Strong Growth as Universal Healthcare Coverage is Expanded
5.9 Indian Antithrombotic Drug Market – Limited by Governmental Healthcare Spending?
5.10 Russian Antithrombotic Drug Market: Limited Healthcare Funding Will Prevent Expansive Growth
6. Antithrombotic Drug Development: R&D Pipeline
6.1 The R&D Pipeline for Antithrombotic Drugs: Overview
6.2 The Antiplatelet Drug R&D Pipeline in 2014
6.2.1 Pozen is Seeking a Strategic Partner for its Antiplatelet Drug, PA32540
6.2.2 The Medicines Company’s Kangrexel (Cangrelor) Awaits Approval
6.3 The R&D Pipeline for Anticoagulants, 2014
6.3.1 Heparins: Little R&D Activity in 2014
6.3.1.1 Will Development of Momenta’s Adomiparin Continue?
6.3.1.2 The Discontinuation of Semuloparin
6.3.2 The Vitamin K Antagonist Pipeline: One Product in Development in 2014
6.3.3 Many Development Direct Thrombin Inhibitors Have Been Discontinued
6.3.4 The Direct Factor Xa Inhibitor Pipeline: Only Two Compounds Remain
6.3.5 Portola Pharmaceuticals’ Betrixaban
6.3.6 Sanofi Has Apparently Discontinued Development of Otamixaban
6.4 The Fibrinolytics R&D Pipeline, 2014
6.4.1 Lundbeck’s Desmoteplase: Failed to Meet Primary Endpoint in Phase III
6.4.2 Bharat Biotech and ThromboGenics’ THR-100
6.5 The R&D Pipeline for Other Antithrombotic Drugs, 2014
6.5.1 Kyowa Hakko Kirin’s KW-3357: Filed in Japan, 2014
6.5.2 Asahi Kasei Pharma America’s ART 123
6.5.3 Regado Biosciences/Tobira Therapeutics is Developing an Anticoagulation System with an Antidote
6.5.4 Isis Pharmaceuticals’ ISIS-FXI Rx
7. Leading Companies in the Antithrombotic Drug Market
7.1 Leading Antithrombotic Drug Manufacturers in 2014
7.2 Sanofi Leads the Market, but is its Position Under Threat?
7.3 Boehringer Ingelheim Captures Market Share
7.4 Bayer Markets Two Antithrombotic Drugs
7.5 Johnson & Johnson Can Achieve Success with a Limited Product Portfolio
7.6 Genentech Will Retain Market Share
7.7 The Medicines Company’s Position Will be Bolstered by the Launch of its New Drug
7.8 Eli Lilly: Market Position is Dependent on Success of Effient
7.9 Otsuka: A Limited Antithrombotic Drug Portfolio
7.10 Pfizer: A Gradually Increasing Share of the Market
7.11 Bristol-Myers Squibb Had a Dramatic Loss of Market Share in 2013
8. Qualitative Analysis of the Antithrombotic Drugs Market, 2015
8.1 The Strengths and Weaknesses of the Antithrombotic Drug Market in 2015
8.1.1 Thrombotic Disease: Management Rather Than Cure
8.1.2 The Lack of Antidotes for the Novel Oral Anticoagulants Restricts the Market
8.2 Opportunities and Threats Facing the Market 2015-2025
8.2.1 Rising Disease Prevalence Creates Opportunities in the Market
8.2.2 Further Development of Existing Drugs
8.2.3 High Demand for Antidotes to the Novel Oral Anticoagulants
8.2.4 The Threat of Generic Competition
8.2.5 High Level of Competition is a Threat to New Entrants – What Can Developers Do?
8.2.6 High Risk of Investment in New Drug Development
8.2.7 Healthcare Budget Pressures Threaten Drug Launches and Prices in Europe
8.3 Social, Technological, Economic and Political Factors Influencing the Antithrombotic Drug Market 2015-2025
8.3.1 Social Factors: An Expanding Patient Population and Increasing Awareness
8.3.2 Technological Advances Encourage the Development of Improved Treatment Options
8.3.3 Economic Factors
8.3.3.1 Cost Cutting in the EU and the US
8.3.3.2 Free Trade within the EU Presents Challenges
8.3.4 Political Factors: Will the Affordable Care Act Increase Patient Access to Antithrombotic Drugs?
9. Research Interviews
9.1 Interview with Dr Sanjay Bhanot, PhD, Vice President of Clinical Development and Translational Medicine, Isis Pharmaceuticals, Inc.
9.1.1 Isis Pharmaceuticals Antithrombotic Drugs Pipeline
9.1.2 ISIS-FXIRx Phase II Results
9.1.3 Trends in the Antithrombotic Drug Market, 2015-2025
9.2 Interview with Dr Marcelo A. Lima, Research Fellow and Professor of Molecular Biology, Department of Biochemistry, Universidade Federal de São Paulo, Brazil
9.2.1 Recent Research on a Novel Heparin-Like Compound Derived From Shrimp
9.2.2 Heparin vs. Novel Oral Anticoagulants
9.2.3 Unmet Needs in Brazil and Worldwide
9.2.4 Trends in the Antithrombotic Drug Market
10. Conclusions from Our Study
10.1 The World Market for Antithrombotic Drugs 2015-2025
10.1.1 The Decline of Antiplatelet Drugs and the Rise of the Anticoagulants
10.2 The Leading National Markets 2015-2025
10.3 Trends in the Industry
10.3.1 The Market Will Recover From Plavix Decline
10.3.2 The Demand for Antithrombotic Drugs is Increasing Worldwide
10.3.3 Many Drugs Will Face Generic Competition Over the Coming 10 Years
10.3.4 High Barriers to Market Entry and a Limited Pipeline – The Implications
【レポート販売概要】
■ タイトル：抗血栓薬の世界市場：抗凝固薬、抗血小板薬■ 英文：Antithrombotic Drugs: World Industry and Market Prospects 2015-2025
■ 発行日：2015年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN5040808
■ 調査対象地域：グローバル
- 公共安全LTE市場（2014-2019）：市場規模、技術、ベンダー動向、周波数割り当てConsidered as the de-facto standard for Public Safety broadband communications, LTE is rapidly gaining momentum within the Public Safety industry. As a result Public Safety agencies, vendors and service provider are heavily investing in Public Safety LTE, with commercial deployments in both the North America and the Middle East region. While initial investments appear promising there still remain …
- リチウムの世界市場：炭酸リチウム、水酸化リチウム、リチウム濃縮物、リチウム金属、ブチルリチウム、塩化リチウムAbout the Lithium Market Lithium is recovered from brine, pegmatites, and sedimentary rocks. It is extracted from brine in the form of lithium chloride. Lithium is derived from spodumene, a commercially exploited hard rock mineral, through acid fusion. Lithium and its derivative compounds are used in many end-use segments such as batteries, ceramics and glass, lubricants, metallurgy, air treatment …
- カーボンナノチューブ（CNT）の世界市場：シングルウォールナノチューブ （SWCNT）、マルチウォールナノチューブ （MWCNT）The global carbon nanotubes market is estimated to reach USD 5.64 Billion by 2020, at a CAGR of 20.1% between 2015 and 2020. Unmatched mechanical and transport properties are the key reasons for the surging demand of carbon nanotubes. Carbon nanotubes are used in various applications such as electronics & semiconductors, chemical & polymers, batteries & capacitors, energy, medical, composites, aer …
- 紙包装の世界市場Visiongain’s comprehensive new 209-page report reveals that the global paper packaging market will reach a value of $303.8 billion in 2018. As such paper packaging still dominates the packaging landscape in many consumer verticals and industrial applications due to its light weight and highly recyclable nature. Are you involved in the paper packaging market or intend to be? If so, then you must re …
- 対空ミサイル防衛レーダー（AMDR）の世界市場：地上レーダーシステム、航空機搭載レーダーシステム、船舶用レーダーシステムAbout Air and Missile Defense Radar System Radar is an object detection system that detects the range, altitude, direction, speed of the approaching and still objects by using radio waves. It is used to detect missiles, spacecraft's, ships, aircrafts, weather formations, and terrain. They are used as an early-warning devices, to spot foe's approaching missiles and airborne systems from great dista …
- 皮膚糸状菌爪真菌症（DO）：企業と競争環境PharmaPoint: Dermatophytic Onychomycosis (DO) - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Dermatophytic Onychomycosis (DO) - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing DO Market. The report identifies and analyses the key companies shaping and dr …
- 幹細胞治療の世界市場2018-2022About Stem Cell Therapy Stem cells are cells that have the ability to divide and differentiate into almost every cell type in the body and used in surgery and medicine. Technavio’s analysts forecast the Global Stem Cell Therapy Market to grow at a CAGR of 10.52% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the stem cell ther …
- 世界の風力エネルギー産業分析：Analyzing the Global Wind Energy IndustryIn many parts of the world, wind energy has already grown to be a mainstream energy source. This growth has long been driven by concerns about global climate change, mainly in the developed world and especially in Europe. Wind energy has emerged as the most attractive solution to the world’s energy challenges. It is clean and fuel-free. Moreover, wind is indigenous and enough wind blows across the …
- 尿失禁ケア製品の世界市場：大人用おむつ、尿道カテーテル、尿失禁スリング、充填剤、尿失禁付属品About Urinary Incontinence Products Urinary incontinence is any involuntary urine leakage; it may occur as a result of a number of deformities, such as abnormal function of the lower urinary tract, overactive bladder, and the result of other illnesses. It is estimated that about 50 percent of women suffer from urinary incontinence at some time in their lives. The prevalence of this in young women …
- 施設園芸の世界市場2016-2020：プラスチック、ガラスAbout Greenhouse Horticulture Greenhouse horticulture is the production of crops within a structured shelter, which ensures customized growing conditions. A majority of greenhouse structures are made of plastic, followed by glass, and other materials. Greenhouses protect crops from diseases, pests, and various unfavorable weather conditions. The benefits of greenhouse horticulture over conventiona …
- 乳製品の代替品の世界市場：ソース別（大豆、アーモンド、米、その他）、用途別（食品、飲料、乳製品を含まないプロバイオティクス飲料、その他）、流通経路別（大規模小売、小規模小売、専門店、オンライン）Dairy alternative based food and beverages are prepared from dairy-free milk, extracted from various plant-based sources. Lactose intolerant and vegan individuals are increasingly consuming dairy alternative based food and beverages. There are wide variety of food and beverages available in the market, prepared from milk, derived from sources such as almond, soy, rice, coconut, and others. Popular …
- 睡眠ポリグラフ装置の世界市場2019-2023Global Polysomnography Devices Market: About this market Technavio’s polysomnography devices market analysis considers sales from hospitals, sleep clinics and diagnostic laboratories, ASCs, and homecare. Our analysis also considers the sales of polysomnography devices in Asia, Europe, North America, and ROW. In 2018, the hospitals' segment had a significant market share, and this trend is expected …
- BRIC（ブラジル/ロシア/インド/中国）の内視鏡検査可視化システム市場BRIC Endoscopy Visualization Systems Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Endoscopy Visualization Systems Market Outlook to 2020", provides key market data on the BRIC Endoscopy Visualization Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - High-End Endoscopy Visualization Sy …
- Acteon, Inc.：市場シェア分析Acteon, Inc. Market Share Analysis Summary GlobalData’s new report, “Acteon, Inc. Market Share Analysis” provides in-depth information on Acteon, Inc.’s market position in the different medical equipment markets it operates in. The report provides Acteon, Inc. market share information in two key market categories – Dental Chairs and Equipment and Dental Radiology Equipment. The report also provide …
- 女性医療の世界市場：閉経後骨粗鬆症、避妊、不妊、閉経、子宮内膜症、多嚢胞性卵巣症候群About Women's Health Market Women’s health refers to the overall well-being experienced by women — this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer). …
